Abayeneh Girma

Prof. Abayeneh Girma

Mekdela Amba University, Dessie, Ethiopia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 October 2023 in The Cell Surface
Verified
Journal Article
Open access
Abayeneh GirmaAbayeneh Girma
Abayeneh Girma
One of the biggest issues for medical professionals and a serious global concern is the emergence of multi-drug-resistant bacteria, which is the result of the overuse or misuse of antimicrobial agents. To combat this urgent problem, new drugs with alternative mechanisms of action are continuously replacing conventional antimicrobials. Nanotechnology-fueled innovations provide patients and medical professionals with hope for overcoming drug resistance. The aim of the present work was to document the antimicrobial potential and mechanisms of action of metallic nanoparticles against bacterial pathogens. Cell wall interaction and membrane penetration, reactive oxygen species (ROS) production, DNA damage, and protein synthesis inhibition were some of the generalised mechanisms recognised in the current study. In vitro and in vivo studies demonstrated that toxicity concerns and the development of bacterial resistance against nanoparticles (NPs) harden the use of metallic NP products for the treatment of drug-resistant bacterial pathogens. Therefore, researchers across the globe should actively engage in solving the above-mentioned issues.

17 September 2022 in Veterinary Medicine International
Verified
Journal Article
Open access
Abayeneh GirmaAbayeneh Girma
Abayeneh Girma
DTDessalew Tamir
Dessalew Tamir
Prevalence of Bovine Mastitis and Its Associated Risk Factors among Dairy Cows in Ethiopia during 2005–2022: A Systematic Review and Meta-Analysis: Bovine mastitis remains a major prevalent disease in cattle and places a significant economic burden on the global dairy industry. The goal of this systematic review and meta-analysis was to examine the overall prevalence of mastitis and its associated risk factors among dairy cows. Scientific articles written in English were recovered from PubMed, ScienceDirect, Web of Science, Google Scholar, Cochrane Library, and other sources from Google Engine and University Library Databases. Prevalence, bovine mastitis, clinical mastitis, subclinical mastitis, associated factors, dairy cows, and Ethiopia were search terms used for this study. For critical appraisal, PRISMA 2009 was applied. Heterogeneity and publication bias were evaluated using Cochrans Q, inverse variance (I2), and funnel plot asymmetry tests. A random-effects model was used to calculate the pooled burden of mastitis and its associated factors among dairy cows, along with the parallel odds ratio (OR) and 95 confidence interval (CI). A total of 6438 dairy cows were included in the 17 eligible studies for this meta-analysis. The overall pooled prevalence of mastitis among dairy cows in Ethiopia was 43.60 (95 CI: 34.71, 52.49), of which 12.59 (95 CI: 7.18, 18.00) and 32.21 (95 CI: 24.68, 39.74) were clinical and subclinical cases, respectively. Of the regions, the highest and lowest pooled prevalence estimates of mastitis among dairy cows were 49.90 (95 CI: 31.77, 68.03) and 25.09 (95 CI: 3.86, 46.32) in the Oromia and Amhara regions, respectively. The highest pooled prevalence estimate in the study period was recorded between 2017 and 2022, with a pooled prevalence estimate of 46.83 (95 CI: 35.68, 57.97), followed by the study period from 2005 to 2016, with a pooled prevalence estimate of 39.97 (95 CI: 25.50, 54.44). Gram-positive bacteria (84.70) were the most prevalent mastitis-causing agents compared with Gram-negative bacteria (15.30). Breed (AOR: 2.17, 95 CI: 1.44, 2.90), lactation stage (AOR: 1.59, 95 CI: 1.04, 2.15), parity (AOR: 3.31, 95 CI: 1.69, 4.94), history of mastitis (AOR: 3.56, 95 CI: 2.40, 4.71), floor type (AOR: 1.59, 95 CI: 0.16, 3.34), and teat injury (AOR: 6.98, 95 CI: 0.33, 13.64) were factors significantly associated with mastitis among dairy cows in Ethiopia. Early diagnosis and proper medication, as well as implementing appropriate prevention and control measures, are necessary for the management of mastitis in dairy cows.


9 November 2021 in Journal of Food Quality
Verified
Journal Article
Open access
PDF file
Abayeneh GirmaAbayeneh Girma
Abayeneh Girma
AAAleka Aemiro
Aleka Aemiro
Fermented Ethiopian traditional dairy products containing LAB that show antibacterial activities against various food spoilage and pathogenic bacteria have been used for the preservation of fermented dairy products for a long time. However, there are no comprehensive scientific reports on the antibacterial activity of LAB isolated from various fermented dairy products in Pawe Woreda. The objective of the study was to evaluate the antibacterial activity of LAB isolated from traditionally fermented Ethiopian dairy products against spoilage and pathogenic bacteria. Thirty-five samples of fermented dairy products were collected from three cattle-farming areas of Pawe Woreda. A total of 97 LAB were isolated and screened primarily using the perpendicular streak plate method against 3 Gram-positive and 3 Gram-negative bacterial strains. Out of the 97 strains, 10 were active against at least two of the tested bacteria, of which 7 strains were selected for secondary screening by their broad-spectrum antibacterial activities. The seven in vitro antibacterial activities of the extract ranged from 5 to 16mm in diameter during the secondary screening. In this study, Z2, Z4, and N2 strains exhibited the highest inhibition zone with broad-spectrum activity against all tested bacteria. The MIC and MBC values range from 0.10 to 0.30µg/µL and 0.20 to 0.50µg/µL, respectively. Following morphological, physiological, biochemical, and molecular characteristics, seven potent strains were identified as Lactobacillus acidophilus, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus rhamnosus, Leuconostoc mesenteroides, Streptococcus thermophilus, and Lactococcus lactis. According to the findings of this study, Ethiopian fermented dairy products were the most potent source of bioactive compounds with potential effects against food spoilage and pathogenic bacterial strains.

13 October 2024 in Nano Select
Verified
Journal Article
Open access
Abayeneh GirmaAbayeneh Girma
Abayeneh Girma
Gedefaw MebratieGedefaw Mebratie
Gedefaw Mebratie
BMBawoke Mekuye
Bawoke Mekuye
BABirhanu Abera
Birhanu Abera
TBTigabu Bekele
Tigabu Bekele
GAGetachew Alamnie
Getachew Alamnie
The increase of antibiotic resistance in bacteria has become a major concern for successful diagnosis and treatment of infectious diseases. Over the past few decades, significant progress has been achieved on the development of nanotechnology‐based medicines for combating multidrug resistance in microorganisms. Among these, metallic nanoparticles (MNPs) hold great promise in addressing this challenge due to their broad‐spectrum and robust antimicrobial properties. This review illustrates the antibacterial activities of MNPs and further elucidates how different factors including synthesis method, size, shape, surface charge, pH, dose, type of capping or stabilizing agents of MNPs, and Gram‐type of the bacteria, impact their antibacterial activities, which are expected to promote the future development of more potent MNP‐based antibacterial agents.

16 January 2024 in IET Nanobiotechnology
Verified
Journal Article
Open access
PDF file
Abayeneh GirmaAbayeneh Girma
Abayeneh Girma
BABirhanu Abera
Birhanu Abera
BMBawoke Mekuye
Bawoke Mekuye
Gedefaw MebratieGedefaw Mebratie
Gedefaw Mebratie
Foodborne disease outbreaks due to bacterial pathogens and their toxins have become a serious concern for global public health and security. Finding novel antibacterial agents with unique mechanisms of action against the current spoilage and foodborne bacterial pathogens is a central strategy to overcome antibiotic resistance. This study examined the antibacterial activities and mechanisms of action of inorganic nanoparticles (NPs) against foodborne bacterial pathogens. The articles written in English were recovered from registers and databases (PubMed, ScienceDirect, Web of Science, Google Scholar, and Directory of Open Access Journals) and other sources (websites, organizations, and citation searching). “Nanoparticles,” “Inorganic Nanoparticles,” “Metal Nanoparticles,” “Metal–Oxide Nanoparticles,” “Antimicrobial Activity,” “Antibacterial Activity,” “Foodborne Bacterial Pathogens,” “Mechanisms of Action,” and “Foodborne Diseases” were the search terms used to retrieve the articles. The PRISMA‐2020 checklist was applied for the article search strategy, article selection, data extraction, and result reporting for the review process. A total of 27 original research articles were included from a total of 3,575 articles obtained from the different search strategies. All studies demonstrated the antibacterial effectiveness of inorganic NPs and highlighted their different mechanisms of action against foodborne bacterial pathogens. In the present study, small‐sized, spherical‐shaped, engineered, capped, low‐dissolution with water, high‐concentration NPs, and in Gram‐negative bacterial types had high antibacterial activity as compared to their counterparts. Cell wall interaction and membrane penetration, reactive oxygen species production, DNA damage, and protein synthesis inhibition were some of the generalized mechanisms recognized in the current study. Therefore, this study recommends the proper use of nontoxic inorganic nanoparticle products for food processing industries to ensure the quality and safety of food while minimizing antibiotic resistance among foodborne bacterial pathogens.